Announcements

16 June 2026
Biomolecules Receives an Increased CiteScore of 9.3


We are pleased to share that Biomolecules (ISSN 2218-273X) has received an increased CiteScore of 9.3 in June 2026. The CiteScore ranks the journal 63 out of 448 titles (Q1) in the “Biochemistry” category, and 77 out of 414 titles (Q1) in the “Molecular Biology” category, an impressive achievement for a journal running in Volume 15.

You can find more statistics on our website.

The current CiteScores measure the average number of citations within a journal over a four-year window (2022–2025). The Scopus database provides a comprehensive suite of metrics that support informed publishing strategies, research evaluation and enable benchmarking of journal performance.

This achievement reflects the collective efforts of our authors, reviewers, and editors. Together we will continue to track the progress of Biomolecules and its growing impact in molecular and cell biology.

8 June 2026
Meet Us at the 2026 Human Proteome Organization World Congress, 27 September–1 October 2026, Singapore


Conference:
2026 Human Proteome Organization World Congress
Date: 27 September–1 October 2026
Location: Singapore

From 27 September to 1 October 2026, MDPI will be attending the 2026 Human Proteome Organization World Congress (HUPO 2026) in Singapore as an exhibitor, welcoming researchers from diverse backgrounds to visit and share their latest ideas.

This year, HUPO 2026 are embracing the theme “Proteomics Plus: Transforming Lives” and are excited to explore how proteomics is shaping the future of health and medicine in ways we could have only dreamed of a few years ago. Proteomics is no longer just a field of study; it is a catalyst for change. From cutting-edge breakthroughs to real-world solutions, the impact of proteomics is undeniable. At this Congress, we will come together to celebrate how our work is transforming lives—from advancing medical treatments to uncovering new ways to understand health on a global scale. It is an opportunity to see how the science is evolving and, most importantly, how it is making a real difference in people’s lives. 

We look forward to meeting you in Singapore for an unforgettable experience at HUPO 2026!

The following MDPI journals will be represented:

If you attend this conference, please feel free to visit our booth. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the official website: https://2026.hupo.org/.

4 June 2026
Open Access, Broadly Recognized: 363 MDPI Journals Receive CiteScores for 2025

The 2025 CiteScore metrics have been officially released by Scopus, and the results confirm what has become a consistent pattern for MDPI's journal portfolio: broad recognition across disciplines, steady improvement across the majority of ranked titles, and a growing presence at the top of subject category rankings.

CiteScore, published annually by Elsevier's Scopus database, measures the average citations received by articles published in a journal over a four-year window. As a complement to the Journal Impact Factor, which uses a two-year window based on the Web of Science database, CiteScore provides an alternative, long-term perspective on citation performance.

The 365 MDPI journals in Scopus (as of May 2026) are indexed across a wide range of subject categories, ensuring that open access research remains highly discoverable to a global readership through one of the most widely used platforms in academic publishing.

Data Summary (2025 CiteScores)

  • New Additions: 41 MDPI journals received a CiteScore for the first time.
  • Trending Upward: 234 of 322 previously ranked journals (73%) saw an increase in their CiteScore compared to last year.
  • High Visibility: 314 journals (86%) rank in Q1 or Q2 in at least one subject category.
  • Elite Performance: 42 journals rank in the top 10% of their subject categories.

Portfolio Performance

Among the 322 journals that held a CiteScore in 2024, 234 saw an increase this year. Quartile improvements outnumbered declines across the portfolio, with 52 journals moving to a higher quartile and only 20 seeing a decline. Furthermore, no previously ranked journals were removed. The 42 journals now ranked in the top 10% of their subject categories are drawn from a strong foundation of 178 journals holding a Q1 position.

With the large majority of our indexed portfolio ranked in the top half of research fields, researchers can confidently choose MDPI to meet funder mandates for high-quality, fully compliant Open Access publishing.

Exceptional Achievements for Foods and Life

Notably, both Foods and Life achieved a 99th percentile ranking in their respective subject categories for the 2025 CiteScores. This outstanding placement positions them as leading journals in their fields and highlights the high visibility and global impact of the open access research they publish.

Journal Metrics and Beyond

Journal-level metrics describe outlets, not individual articles. An increasing number of funders and institutions—including signatories of DORA and the Coalition for Advancing Research Assessment—now explicitly encourage evaluation at the article level rather than by the journal in which research appears. MDPI supports this direction: we report CiteScore alongside the Journal Impact Factor, Journal Citation Indicator, and article-level usage data because no single number captures the full reach and contribution of published research.

Thank You

These results reflect the sustained effort of thousands of editors-in-chief, editorial board members, reviewers, and authors across every field MDPI serves. The metrics are the outcome; the work is yours.

To explore the specific 2025 CiteScore, Impact Factor, and indexing details for your field's journal, please visit the Scopus journals list and go to a journal's Statistics page.

1 June 2026
MDPI INSIGHTS: The CEO’s Letter #35 – 30 Years of Open Science, Open Access Policies, Spain Summit, MMCS 2026 & Antibiotics 2026

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

30 Years of Open Science, Built Together

This month, we officially launched MDPI’s 30th Anniversary campaign and dedicated anniversary website, marking an important milestone in our journey as an open access publisher. What began in 1996 with a single journal and the simple belief that scientific knowledge should be shared openly and freely has grown into a global publishing organization supporting more than 500 journals, 68,000 Editorial Board Members, and millions of researchers worldwide.

The anniversary page, entitled 30 Years of Open Science, Built Together, reflects on the people, milestones, and partnerships that have shaped MDPI over the past three decades. It includes a retrospective of our development, key moments in the evolution of open access, landmark research articles, journal anniversaries, an interview with the CEO, and perspectives from colleagues and partners who have contributed to our success.

Looking back, one of the most striking aspects of our journey is not simply our growth, but the broader transformation of scholarly publishing itself.

Open access has moved from a niche concept to a widely adopted publishing model, helping make research more accessible, discoverable, and impactful for researchers, institutions, policymakers, and society.

MDPI has been part of this transition and continues to invest in the people, technology, partnerships, and research integrity infrastructure needed to support high-quality open science at scale.

While anniversaries naturally encourage reflection, they are also an opportunity to look ahead. The challenges facing scholarly publishing today, including research integrity, artificial intelligence, accessibility, and global participation in science, will require continued collaboration across the research ecosystem. As we celebrate 30 years of publishing, our focus remains on supporting researchers, strengthening trust in open science, and helping shape the future of scholarly communication together.

I encourage you to visit the anniversary page, explore the milestones, and take a moment to reflect on the role each of us has played in contributing to MDPI’s story.

Thank you for being part of this journey.

Impactful Research

Highlights from MMCS 2026 in Beijing (14-17 May)

From 14–17 May, MDPI hosted The 5th Molecules Medicinal Chemistry Symposium (MMCS 2026) in Beijing, China, bringing together academia and industry to explore advances in chemical biology, medicinal chemistry, and drug discovery.

The conference hosted more than 230 attendees from 37 countries and regions, alongside 257 submissions and 145 accepted abstracts. With a significant increase in attendance – up by 100 participants compared with the previous edition – the popularity of MMCS continues to grow in terms of its international profile and scientific relevance within this rapidly evolving field.

The scientific program covered seven themes:

  • Chemical Biology for Drug Discovery
  • Medicinal Chemistry Research Progress
  • Natural Products in Drug Discovery
  • AI-enabled Drug Discovery
  • GPCR & Ion Channel Targeted Drug Development
  • Innovative Proximity-Based Drug Modalities
  • Biocatalysis for Natural Product & Drug Synthesis

The event featured three plenary speakers, 14 keynote speakers, 35 selected oral presentations, and 98 poster presentations, creating opportunities for open scientific exchange and collaboration. Conference Chair Prof. Dr. Diego Muñoz-Torrero described this edition as one of the most successful MMCS events to date.

Thanks to our Sponsors

MMCS 2026 secured sponsorship support from 12 industrial partners, 11 of which set up on-site exhibition booths. Covering biopharmaceutical R&D, life science supplies, pharmaceutical experimental instruments, and industrial service sectors, exhibitors were able to connect their businesses directly with attendees and make connections at the conference.

30th Anniversary Celebration of Molecules

During the conference, we also celebrated the 30th anniversary of Molecules, one of MDPI’s flagship journals. The celebration brought together Section Editors-in-Chief, Editorial Board Members, MDPI leadership, and editorial colleagues to reflect on the journal’s development, achievements, and continued future growth.

Events such as MMCS 2026 highlight the important role conferences play in creating scientific exchange and collaboration, and in connecting our research communities in person.

They also reflect the continued development of MDPI’s conference portfolio and our commitment to supporting academic engagement beyond publishing alone. Thanks to everyone involved in organizing and contributing to the success of this event.

Inside MDPI

Open Access Policies Continue to Accelerate Globally

One of the clearest indicators of the continued momentum behind open access is the growing number of national and institutional policies supporting, and increasingly requiring, open dissemination of research.

Around the world, governments, funding agencies, and universities are building their open access mandates, with increasing focus on transparency, rights retention, and public accessibility of publicly funded research. While these policies vary across regions, the broader direction is clear: expectations around openness and compliance continue to accelerate.

For researchers, navigating these evolving requirements can be complex and time-consuming. Supporting the research community therefore means not only publishing high-quality open access content but also helping stakeholders better understand changing requirements and emerging opportunities. At MDPI, we see this as an important part of our role within scholarly communication.

“Expectations around openness and compliance continue to accelerate”

Through the MDPI Blog, our Content team continues to publish monthly articles overviewing different countries’ relationships with open access, exploring their histories, policies, opportunities, and statistics. All this information is centralized into an article which contains brief summaries of each country, with links to all the full articles, and is updated monthly.

Recent Policy Developments

South Africa

In 2026, South Africa’s Department of Science and Innovation introduced the South African Open Science Policy. The policy states that: “Open access shall be required for publications arising from publicly funded research, and desirable for research from all sources of funding.”

The policy envisions a coordinated and broad approach to open science that will sustainably and ethically drive socio-economic development by increasing the practice of open science through policy, training, incentivization, and infrastructure.

Canada

In Canada, the Tri-Agency OA Policy on Publications was revised, removing the 12-month embargo for research that must be deposited in a repository with an open license and with author rights retained.

The Agencies argue that “societal advancement is made possible through widespread and barrier-free access to cutting-edge research and knowledge.”

Chile

Chile is a collaborative and engaged member of the global open access movement.

The National Research and Development Agency (Agencia Nacional de Investigación y Desarrollo, or ANID) is Chile’s main funding agency for R&D. It mandates that all beneficiaries must deposit the final version of their published scientific output, with an embargo period of up to 12 months, into a repository.

ANID also supports the InES Open Science funding program, which allows universities to request funding for capacity and infrastructure building. Further, Chile is an active participant in various international initiatives, such as Redalyc, SciELO, and Red de Repositorios Latinoamericanos.

Openness Beyond Research

At MDPI, openness remains one of our core values, ensuring that research outputs are freely accessible to anyone. This commitment also extends to sharing knowledge about the scholarly publishing landscape itself, which we practice on the MDPI Blog through various topics, including open access, recent advances in science, and opportunities for researchers.

As the open access landscape continues to evolve, helping researchers, institutions, editors, and partners navigate these changes will remain an important priority for us.

Thank You

I would like to thank Jack McKenna (Senior Content Specialist, MDPI) from our Content team for his ongoing work on the MDPI Blog series covering global open access policy developments. Initiatives such as this help make complex policy discussions more accessible and useful to the wider research community.

Coming Together for Science

Reflections from the MDPI Spain Summit 2026 in Valencia (21 May)

On 21 May, we hosted the MDPI Spain Summit 2026 in Valencia.

The Summit brought together 30 Editorial Board Members and MDPI colleagues for a discussions on the future of publishing, research integrity, peer review, artificial intelligence, and the evolving research landscape in Spain.

We hosted participants from leading Spanish institutions and spoke on the importance of Spain as a major contributor to global open access (OA) research. In 2025 alone, Spain ranked among the leading countries worldwide for OA publishing, with more than 85% of publications made openly accessible. MDPI also continues to play a significant role within the Spanish research ecosystem.

MDPI in Spain

Spain remains one of MDPI's most important academic markets and a leading contributor to OA research globally. Ever since our Barcelona office opened in 2016 (Happy 10th Anniversary!), MDPI Spain has been actively supporting researchers, institutions, societies, and academic partners across the country. Today, the office plays an important role in creating engagement with the Spanish scholarly community through editorial support, partnerships, conferences, training initiatives, and outreach activities.

A cluster of high-level indicators highlight both the strength of the local research ecosystem and MDPI’s role within it:

  • 43,218 total publications in Spain in 2025, of which 35,728 (83%) were open access (49% Gold OA).
  • 211,200+ total publications (2021–2025), with 84% published open access.
  • 13,444 MDPI publications from Spanish institutions in 2025, representing 14% of all open access publications in Spain.
  • More than115,100 MDPI publications from Spanish institutions since 1996.
  • More than 4,500 Editorial Board Members from Spain, including more than 150 Chief Editors and 57 Associate Editors.
  • 42 institutional partners participating in MDPI’s Institutional Open Access Program (IOAP).
  • Spain ranks second globally for MDPI society affiliations, with 26 affiliated society agreements currently in place.

Program Overview

What made this summit special was the openness of the discussions around the research landscape in Spain and the role MDPI plays within the market. General topics of the presentations included:

  • MDPI Introduction – Stefan Tochev (CEO).
  • Engagement with the Academic Community – Dr. Marta Colomer (External Affairs Lead).
  • Latest Developments in the Editorial Process – Dr. Jordi Martinez (Deputy Managing Editor).
  • Research integrity and Publication Ethics – Slavomir Nikodijevic (Research Integrity Specialist).
  • A 360 View of Academic Publishing – Prof. Dr. Luis Angel Ruiz Fernandez (EBM of Remote Sensing).

Panel Discussion

We also hosted a panel discussion moderated by Marta, entitled “The Future of Academic Publishing” with Prof. Luis Ruiz, Prof. Marta Feliz (EBM of the journal Catalysts), Dr. Enric Sayas (Product Owner, AI & Technology Innovation), and myself. The discussion looked at the evolving role of editors, the future of peer review, and the growing importance of maintaining trust, ethics, and research integrity in an era increasingly influenced by artificial intelligence.

Themes from the Summit

Several themes emerged throughout the discussions, reflecting broader conversations taking place across publishing:

  • The academic community values efficient publishing workflows, but expectations around scientific quality and editorial rigor continue to rise.
  • Reviewer fatigue and long-term sustainability of peer review remain major challenges across the industry.
  • AI is rapidly changing scholarly communication and requires transparent and responsible governance.
  • Reputation and trust continue to depend on long-term engagement, transparency, and quality-focused decision-making.

“Maintaining an open dialogue with researchers, editors, reviewers, and institutions remains a priority for MDPI”

It was constructive to see the willingness of participants to engage directly and candidly with us. These conversations provide insights that help inform how we continue to develop our editorial processes, engagement activities, and support for the research community. While certain discussions included concerns, there was also recognition that open dialogue between publishers and the research community is essential if we want to improve scholarly communication together.

Events such as this are increasingly important for MDPI. They allow us to present our perspective, to listen to the experiences, expectations, and concerns of editors, reviewers, and researchers, and to address these accordingly.

Thank You

Thank you to our Barcelona Office and all colleagues involved in organizing the summit, as well as all participants for contributing to these thoughtful and constructive discussions.

As publishing continues to evolve, maintaining an open dialogue with researchers, editors, reviewers, and institutions remains an important priority for MDPI. Events such as the Spain Summit play an important role in helping us to build relationships, foster trust, and better understand the needs of our community.

Closing Thoughts

Highlights from Antibiotics 2026 in Barcelona (11–14 May)

This week, MDPI hosted the Antibiotics 2026 — Advances in Antimicrobial Action and Resistance conference in Barcelona, bringing together academics and industry experts to discuss one of the most important scientific and public health challenges of our time: antimicrobial resistance.

The conference welcomed 145 attendees from 42 different countries and territories, alongside 265 submissions and 127 accepted abstracts, showing the international reach of the event and the strong scientific interest in this rapidly evolving field.

Scientific Exchange on a Global Challenge

Antimicrobial resistance continues to be a global concern, creating collaboration across disciplines, institutions, and regions. The conference program focused on a range of topics including:

  • Antimicrobial resistance mechanisms
  • One Health approaches to antimicrobial stewardship
  • Discovery of novel antimicrobial agents
  • Innovation in clinical strategies and treatment approaches
  • Ethnopharmacology and emerging therapies

Through keynote plenaries, invited lectures, oral presentations, and poster sessions, the conference created a platform for dialogue and scientific exchange.

International Participation and Collaboration

One of the highlights of the event was the diversity of participation across both geography and expertise. Researchers and speakers from Europe, North America, Asia, Africa, Australia, and Latin America took part in discussions throughout the conference, highlighting the global nature of both the challenge and the scientific response.

The scientific program included:

  • 2 keynote speakers
  • 10 invited speakers
  • 36 selected talks
  • 78 posters

The conference brought together perspectives from academia, healthcare, and industry, helping facilitate interdisciplinary collaboration around future approaches to antimicrobial research and resistance management.

The Role of Conferences in Scholarly Communication

Conferences are an important platform for collaboration, scientific exchange, and community-building. Events such as Antibiotics 2026 show the value of bringing researchers together in person to discuss emerging challenges, share new findings, and strengthen international networks across disciplines and regions.

Thank You

I would like to thank the conference chairs, speakers, participants, sponsors, and the entire MDPI conference team for their work in making this event a success. The engagement and positive feedback from attendees highlight the importance of our events in addressing some of the most pressing scientific challenges facing society today.

Stefan Tochev
Chief Executive Officer
MDPI AG

26 May 2026
Biomolecules | Highly Cited Papers in 2025–2026 in the “Molecular Reproduction” Section


As all articles published in our journal are open access, you have free, unlimited access to the full text. We invite you to read our most highly cited papers published in 2025 and 2026, which are listed below:

1. “HOXA10 and HOXA11 in Human Endometrial Benign Disorders: Unraveling Molecular Pathways and Their Impact on Reproduction”
by Lorin-Manuel Pîrlog, Andrada-Adelaida Pătrășcanu, Mara-Diana Ona, Andreea Cătană and Ioana Cristina Rotar
Biomolecules 2025, 15(4), 563; https://doi.org/10.3390/biom15040563
Full text available online: https://www.mdpi.com/2218-273X/15/4/563

2. “Molecular Biomarkers for Timely and Personalized Prediction of Maternal-Fetal Health Risk”
by Daniel Estrela, Rita F. Santos, Alice Masserdotti, Antonietta Silini, Ornella Parolini, Inês Mendes Pinto and Andrea Cruz
Biomolecules 2025, 15(3), 312; https://doi.org/10.3390/biom15030312
Full text available online: https://www.mdpi.com/2218-273X/15/3/312

3. “Revolutionizing Implantation Studies: Uterine-Specific Models and Advanced Technologies”
by Shu-Yun Li and Francesco John DeMayo
Biomolecules 2025, 15(3), 450; https://doi.org/10.3390/biom15030450
Full text available online: https://www.mdpi.com/2218-273X/15/3/450

4. “Blastocyst-Derived Lactate as a Key Facilitator of Implantation”
by Kathryn H. Gurner and David K. Gardner
Biomolecules 2025, 15(1), 100; https://doi.org/10.3390/biom15010100
Full text available online: https://www.mdpi.com/2218-273X/15/1/100

5. “Conceptus Elongation, Implantation, and Early Placental Development in Species with Central Implantation: Pigs, Sheep, and Cows”
by Gregory A. Johnson, Thainá Minela, Heewon Seo, Fuller W. Bazer, Robert C. Burghardt, Guoyao Wu, Ky G. Pohler, Claire Stenhouse, Joe W. Cain, Zachary K. Seekford et al.
Biomolecules 2025, 15(7), 1037; https://doi.org/10.3390/biom15071037
Full text available online: https://www.mdpi.com/2218-273X/15/7/1037

6. “LIFR-Mediated ERBB2 Signaling Is Essential for Successful Embryo Implantation in Mice”
by Jumpei Terakawa, Sakura Nakamura, Mana Ohtomo, Saki Uehara, Yui Kawata, Shunsuke Takarabe, Hibiki Sugita, Takafumi Namiki, Atsuko Kageyama, Michiko Noguchi et al.
Biomolecules 2025, 15(5), 698; https://doi.org/10.3390/biom15050698
Full text available online: https://www.mdpi.com/2218-273X/15/5/698

7. “Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration”
by Julia Delenko, Nathaniel Hyman, Prodyot K. Chatterjee, Polona Safaric Tepes, Andrew J. Shih, Xiangying Xue, Jane Gurney, Andrew G. Baker, Cheng Wei, Daniel Munoz Espin et al.
Biomolecules 2025, 15(6), 873; https://doi.org/10.3390/biom15060873
Full text available online: https://www.mdpi.com/2218-273X/15/6/873

8. “Unraveling the Multi-Omic Landscape of Extracellular Vesicles in Human Seminal Plasma”
by Laura Governini, Alesandro Haxhiu, Enxhi Shaba, Lorenza Vantaggiato, Alessia Mori, Marco Bruttini, Francesca Loria, Natasa Zarovni, Paola Piomboni, Claudia Landi et al.
Biomolecules 2025, 15(6), 836; https://doi.org/10.3390/biom15060836
Full text available online: https://www.mdpi.com/2218-273X/15/6/836

9. “The Role of Preconception Parental Health on Embryo Quality—Preliminary Results of a Prospective Study Using Non-Invasive Preimplantation Genetic Testing for Aneuploidy”
by Maja Tomic, Eda Bokal-Vrtacnik and Martin Stimpfel
Biomolecules 2025, 15(9), 1215; https://doi.org/10.3390/biom15091215
Full text available online: https://www.mdpi.com/2218-273X/15/9/1215

10. “Female Reproductive Tract Organoids: Applications from Physiology to Pathology”
by Xinyu Wang, Diqi Yang and Hui Peng
Biomolecules 2025, 15(7), 925; https://doi.org/10.3390/biom15070925
Full text available online: https://www.mdpi.com/2218-273X/15/7/925

26 May 2026
Biomolecules | Highly Cited Papers in 2025–2026 in the “Molecular Biomarkers” Section


As all articles published in our journal are open access, you have free, unlimited access to the full text. We invite you to read our most highly cited papers published in 2025 and 2026, which are listed below:

1. “A Comprehensive Oncological Biomarker Framework Guiding Precision Medicine”
by Reza Bayat Mokhtari, Manpreet Sambi, Faezeh Shekari, Kosar Satari, Roya Ghafoury, Neda Ashayeri, Paige Eversole, Narges Baluch, William W. Harless, Lucia Anna Muscarella et al.
Biomolecules 2025, 15(9), 1304; https://doi.org/10.3390/biom15091304
Full text available online: https://www.mdpi.com/2218-273X/15/9/1304

2. “Epigenetic Biomarkers in Thoracic Aortic Aneurysm, Dissection, and Bicuspid Aortopathy: A Comprehensive Review”
by Dimitrios E. Magouliotis, Serge Sicouri, Noah Sicouri, Massimo Baudo, Francesco Cabrucci, Yoshiyuki Yamashita and Basel Ramlawi
Biomolecules 2025, 15(4), 568; https://doi.org/10.3390/biom15040568
Full text available online: https://www.mdpi.com/2218-273X/15/4/568

3. “The Impact of the Microbiota on the Immune Response Modulation in Colorectal Cancer”
by Ana Iulia Neagu, Marinela Bostan, Vlad Alexandru Ionescu, Gina Gheorghe, Camelia Mia Hotnog, Viviana Roman, Mirela Mihaila, Simona Isabelle Stoica, Camelia Cristina Diaconu, Carmen Cristina Diaconu et al.
Biomolecules 2025, 15(7), 1005; https://doi.org/10.3390/biom15071005
Full text available online: https://www.mdpi.com/2218-273X/15/7/1005

4. “Gene Expression Analysis and Validation of a Novel Biomarker Signature for Early-Stage Lung Adenocarcinoma”
by Sanjan S. Sarang, Catherine M. Cahill and Jack T. Rogers
Biomolecules 2025, 15(6), 803; https://doi.org/10.3390/biom15060803
Full text available online: https://www.mdpi.com/2218-273X/15/6/803

5. “Impact of Aging and Pathologies on Human Oral Mucosa: Preliminary Investigation of Biophysical Markers from Thermal and Vibrational Analyses”
by Valérie Samouillan, Camille Ober and Marie-Hélène Lacoste-Ferré
Biomolecules 2025, 15(7), 978; https://doi.org/10.3390/biom15070978
Full text available online: https://www.mdpi.com/2218-273X/15/7/978

6. “Growth Differentiation Factor 15 Predicts Cardiovascular Events in Peripheral Artery Disease”
by Ben Li, Farah Shaikh, Houssam Younes, Batool Abuhalimeh, Abdelrahman Zamzam, Rawand Abdin and Mohammad Qadura
Biomolecules 2025, 15(7), 991; https://doi.org/10.3390/biom15070991
Full text available online: https://www.mdpi.com/2218-273X/15/7/991

7. “The Prognostic, Predictive and Clinicopathological Implications of KRT81/HNF1A- and GATA6-Based Transcriptional Subtyping in Pancreatic Cancer”
by Michael Guenther, Sai Agash Surendran, Lea Margareta Steinke, Iduna Liou, Melanie Alexandra Palm, Volker Heinemann, Michael Haas, Stefan Boeck and Steffen Ormanns
Biomolecules 2025, 15(3), 426; https://doi.org/10.3390/biom15030426
Full text available online: https://www.mdpi.com/2218-273X/15/3/426

8. “Copeptin as a Biomarker in Chronic Kidney Disease—A Systematic Review and Meta-Analysis”
by Gabi Gazi, Robert Cristian Cruciat, Daniel-Corneliu Leucuta, Nahlah Al Srouji, Stefan-Lucian Popa, Mohamed Ismaiel, Dinu Iuliu Dumitrascu and Abdulrahman Ismaiel
Biomolecules 2025, 15(6), 845; https://doi.org/10.3390/biom15060845
Full text available online: https://www.mdpi.com/2218-273X/15/6/845

9. “Tauopathies: Calmodulin Regulates Tau Hyperphosphorylation and Its Transformation into Disease-Specific Aggregates”
by Danton H. O’Day
Biomolecules 2025, 15(8), 1133; https://doi.org/10.3390/biom15081133
Full text available online: https://www.mdpi.com/2218-273X/15/8/1133

10. “Fecal Calprotectin as a Prognostic Biomarker for Mortality and Renal Outcomes in Chronic Kidney Disease”
by So Young Lee, Kyungdo Han, Hyuk-Sang Kwon, Eun Sil Koh and Sungjin Chung
Biomolecules 2025, 15(4), 557; https://doi.org/10.3390/biom15040557
Full text available online: https://www.mdpi.com/2218-273X/15/4/557

26 May 2026
Biomolecules | Highly Cited Papers in 2025–2026 in the “Molecular Biology” Section


As all articles published in our journal are open access, you have free, unlimited access to the full text. We invite you to read our most highly cited papers published in 2025 and 2026, which are listed below:

1. “The Balance of MFN2 and OPA1 in Mitochondrial Dynamics, Cellular Homeostasis, and Disease”
by Paola Zanfardino, Alessandro Amati, Mirko Perrone and Vittoria Petruzzella
Biomolecules 2025, 15(3), 433; https://doi.org/10.3390/biom15030433
Full text available online: https://www.mdpi.com/2218-273X/15/3/433

2. “Pathological and Inflammatory Consequences of Aging”
by Mario García-Domínguez
Biomolecules 2025, 15(3), 404; https://doi.org/10.3390/biom15030404
Full text available online: https://www.mdpi.com/2218-273X/15/3/404

3. “Calcium Signaling Dynamics in Vascular Cells and Their Dysregulation in Vascular Disease”
by Chang Dai and Raouf A. Khalil
Biomolecules 2025, 15(6), 892; https://doi.org/10.3390/biom15060892
Full text available online: https://www.mdpi.com/2218-273X/15/6/892

4. “Interplay Between Vascular Dysfunction and Neurodegenerative Pathology: New Insights into Molecular Mechanisms and Management”
by Avanthika Mekala and Hongyu Qiu
Biomolecules 2025, 15(5), 712; https://doi.org/10.3390/biom15050712
Full text available online: https://www.mdpi.com/2218-273X/15/5/712

5. “The Role of IL-6 in Ischemic Stroke”
by Hanna Pawluk, Alina Woźniak, Agnieszka Tafelska-Kaczmarek, Agnieszka Kosinska, Mateusz Pawluk, Krzysztof Sergot, Renata Grochowalska and Renata Kołodziejska
Biomolecules 2025, 15(4), 470; https://doi.org/10.3390/biom15040470
Full text available online: https://www.mdpi.com/2218-273X/15/4/470

6. “Thyroid Hormones and Metabolism Regulation: Which Role on Brown Adipose Tissue and Browning Process?”
by Laura Sabatino and Cristina Vassalle
Biomolecules 2025, 15(3), 361; https://doi.org/10.3390/biom15030361
Full text available online: https://www.mdpi.com/2218-273X/15/3/361

7. “β-Catenin: A Key Molecule in Osteoblast Differentiation”
by Edyta Wróbel, Piotr Wojdasiewicz, Agnieszka Mikulska and Dariusz Szukiewicz
Biomolecules 2025, 15(7), 1043; https://doi.org/10.3390/biom15071043
Full text available online: https://www.mdpi.com/2218-273X/15/7/1043

8. “Circadian Biomarkers in Humans: Methodological Insights into the Detection of Melatonin and Cortisol”
by Cene Skubic, Urša Zevnik, Katarina Nahtigal, Leja Dolenc Grošelj and Damjana Rozman
Biomolecules 2025, 15(7), 1006; https://doi.org/10.3390/biom15071006
Full text available online: https://www.mdpi.com/2218-273X/15/7/1006

9. “Unravelling the Connection Between Energy Metabolism and Immune Senescence/Exhaustion in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome”
by Jente Van Campenhout, Yanthe Buntinx, Huan-Yu Xiong, Arne Wyns, Andrea Polli, Jo Nijs, Joeri L. Aerts, Thessa Laeremans and Jolien Hendrix
Biomolecules 2025, 15(3), 357; https://doi.org/10.3390/biom15030357
Full text available online: https://www.mdpi.com/2218-273X/15/3/357

10. “Exploring the Antioxidant Roles of Cysteine and Selenocysteine in Cellular Aging and Redox Regulation”
by Marta Pace, Chiara Giorgi, Giorgia Lombardozzi, Annamaria Cimini, Vanessa Castelli and Michele d’Angelo
Biomolecules 2025, 15(8), 1115; https://doi.org/10.3390/biom15081115
Full text available online: https://www.mdpi.com/2218-273X/15/8/1115

11. “Immunohistochemical Detection of PIEZO Ion Channels in the Human Carotid Sinus and Carotid Body”
by Elda Alba, Yolanda García-Mesa, Ramón Cobo, Patricia Cuendias, José Martín-Cruces, Iván Suazo, Graciela Martínez-Barbero, José A. Vega, Olivia García-Suárez and Teresa Cobo
Biomolecules 2025, 15(3), 386; https://doi.org/10.3390/biom15030386
Full text available online: https://www.mdpi.com/2218-273X/15/3/386

12. “Neuroprotective Potential of Origanum majorana L. Essential Oil Against Scopolamine-Induced Memory Deficits and Oxidative Stress in a Zebrafish Model”
by Ion Brinza, Razvan Stefan Boiangiu, Iasmina Honceriu, Ahmed M. Abd-Alkhalek, Samir M. Osman, Omayma A. Eldahshan, Elena Todirascu-Ciornea, Gabriela Dumitru and Lucian Hritcu
Biomolecules 2025, 15(1), 138; https://doi.org/10.3390/biom15010138
Full text available online: https://www.mdpi.com/2218-273X/15/1/138

13. “Oxidative DNA Damage and Repair Dynamics in Multiple Sclerosis: Insights from Comet Assay Kinetics, Base Excision Repair Gene Expression, and Genotype Analysis”
by Beata Filipek, Anna Macieja, Aleksandra Binda, Rafal Szelenberger, Leslaw Gorniak, Elzbieta Miller, Mariola Swiderek-Matysiak, Mariusz Stasiolek, Ireneusz Majsterek and Tomasz Poplawski
Biomolecules 2025, 15(6), 756; https://doi.org/10.3390/biom15060756
Full text available online: https://www.mdpi.com/2218-273X/15/6/756

14. “Progressive Alcohol-Related Brain Atrophy and White Matter Pathology Are Linked to Long-Term Inhibitory Effects on mTOR Signaling”
by Ming Tong, Camilla Homans, William Pelit, Busra Delikkaya and Suzanne M. de la Monte
Biomolecules 2025, 15(3), 413; https://doi.org/10.3390/biom15030413
Full text available online: https://www.mdpi.com/2218-273X/15/3/413

15. “Functional Analysis of Direct In Vitro Effect of Phosphorylated Tau on Mitochondrial Respiration and Hydrogen Peroxide Production”
by Zdeněk Fišar and Jana Hroudová
Biomolecules 2025, 15(4), 495; https://doi.org/10.3390/biom15040495
Full text available online: https://www.mdpi.com/2218-273X/15/4/495

21 May 2026
Meet Us at the ISSCR 2026 Annual Meeting, 8–11 July 2026, Montréal, Canada


MDPI will attend the ISSCR 2026 Annual Meeting taking place from 8 to 11 July 2026 in Montréal, Canada.

Leaders in stem cell research and regenerative medicine gather annually for the ISSCR Annual Meeting, and you are invited to be part of it! Join nearly 3500 scientists from across the world at ISSCR 2026 for a four-day event highlighting the most important breakthroughs in the field.

MDPI is excited to participate in this prestigious event. We welcome you to visit our booth, where you will be able to have face-to-face exchanges with our representatives, learn more about our open access publishing services, and receive gifts.

The following MDPI journals will be represented:

If you plan to attend this event, we encourage you to visit our booth and speak to our representatives. We are eager to meet you in person and assist you with any queries that you may have. For more information about the conference, please visit the official website: https://www.isscr2026.org/.

14 May 2026
Meet Us at the ncRNA2026: From Molecular Mechanisms to Clinical Impact, 24–26 June 2026, Leuven, Belgium


MDPI will be attending the international conference “ncRNA2026: From Molecular Mechanisms to Clinical Impact” in Leuven, Belgium, which will take place from 24 to 26 June 2026. In recent years, non-coding RNA studies have revolutionized our understanding of gene regulation, cellular networks, and disease mechanisms. ncRNA2026 will showcase the latest breakthroughs in ncRNA biology and technology through a program dedicated entirely to this field—from molecular mechanisms and clinical applications to data science and translational insights. The conference will feature distinguished international invited speakers, complemented by a strong selection of oral and poster presentations from submitted abstracts.

The following MDPI journals will be represented:

If you are attending the conference, please feel free to visit our booth. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following link: https://sciforum.net/event/ncRNA2026.

13 May 2026
Meet Us at the American Society for Virology 45th Annual Meeting (ASV), 27–30 July 2026, Minneapolis, USA


Conference: The American Society for Virology 45th Annual Meeting (ASV)
Date: 27–30 July 2026
Location: Minneapolis, USA

MDPI will attend the American Society for Virology 45th Annual Meeting (ASV) as an exhibitor. This meeting will be held in Minneapolis, USA, from 27 to 30 July 2026. 

ASV meetings are among the largest and most important virology conferences in the world. These meetings provide a forum to promote discussion and collaboration among scientists active in all aspects of virology, from basic research to vaccines and antiviral therapeutics. The meeting attracts 1400-1800 national and international scientists for a program crafted from over 1000 participant-submitted abstracts, 17 invited symposium speakers, and 6 distinctive state-of-the-art speakers.

The following open access journals will be represented:

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at our booth and answering any questions you may have. For more information about the conference, please visit the following website: https://www.asv.org/asv2026.

Back to TopTop